Medical interventions
Medical interventions ( 5 Questions)
A nurse is caring for a client who is experiencing postpartum hemorrhage.
Which medication should the nurse anticipate administering to inhibit fibrinolysis and reduce blood loss?
Pitocin (oxytocin) is a medication that stimulates uterine contractions and is used to prevent or treat uterine atony, which is the most common cause of postpartum hemorrhage.
However, it does not inhibit fibrinolysis.
Carboprost tromethamine (Hemabate) is a prostaglandin that also stimulates uterine contractions and is used to treat postpartum hemorrhage due to uterine atony.
However, it does not inhibit fibrinolysis.
Methylergonovine maleate (Methergine) is an ergot alkaloid that also stimulates uterine contractions and is used to treat postpartum hemorrhage due to uterine atony.
However, it does not inhibit fibrinolysis.
Misoprostol (Cytotec) is another prostaglandin that also stimulates uterine contractions and is used to prevent or treat postpartum hemorrhage due to uterine atony.
However, it does not inhibit fibrinolysis.
Tranexamic acid (TXA) is a medication that inhibits fibrinolysis and reduces blood loss in postpartum hemorrhage. According to a practice guideline from the International Federation of Gynecology and Obstetrics (FIGO), tranexamic acid given within three hours of vaginal delivery after 500 mL of blood loss reduces mortality by up to 30%.
Normal ranges for blood loss after vaginal delivery are ...
Tranexamic acid (TXA) is a medication that inhibits fibrinolysis and reduces blood loss in postpartum hemorrhage. According to a practice guideline from the International Federation of Gynecology and Obstetrics (FIGO), tranexamic acid given within three hours of vaginal delivery after 500 mL of blood loss reduces mortality by up to 30%.
Choice A is wrong because pitocin (oxytocin) is a medication that stimulates uterine contractions and is used to prevent or treat uterine atony, which is the most common cause of postpartum hemorrhage.
However, it does not inhibit fibrinolysis.
Choice B is wrong because carboprost tromethamine (Hemabate) is a prostaglandin that also stimulates uterine contractions and is used to treat postpartum hemorrhage due to uterine atony.
However, it does not inhibit fibrinolysis.
Choice C is wrong because methylergonovine maleate (Methergine) is an ergot alkaloid that also stimulates uterine contractions and is used to treat postpartum hemorrhage due to uterine atony.
However, it does not inhibit fibrinolysis.
Choice D is wrong because misoprostol (Cytotec) is another prostaglandin that also stimulates uterine contractions and is used to prevent or treat postpartum hemorrhage due to uterine atony.
However, it does not inhibit fibrinolysis.
Normal ranges for blood loss after vaginal delivery are ...